SIOP awards Dr. Andy Wood for Best Translational Research Abstract for neuroblastoma research conducted at Children's Hospital of Philadelphia.
The Hospital is now enrolling pediatric cancer patients in an innovative clinical trial, called CART19, that programs the immune system to attack blood cancers. Researchers will modify a child’s own T cells to attack specific types of cancer in their B cells.
In genome-wide study, researchers at The Children’s Hospital of Philadelphia have discovered two gene variants that raise the risk of the pediatric cancer neuroblastoma. The study broadens understanding of how gene changes may put a child at risk of deveoping neuroblastoma.
The Cancer Center at The Children's Hospital of Philadelphia is proud to announce two new grants totaling $455,582 from The St. Baldrick's Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research.
International campaign aims to improve the health of babies worldwide by educating the public about the important benefits of breastfeeding.
Proceeds support live-saving treatments pioneered at the Center for Fetal Diagnosis and Treatment.
Less than four years after opening the Garbose Family Special Delivery Unit, the world’s first birth facility exclusively for mothers carrying babies with known birth defects, CHOP celebrates 1,000 deliveries.
The first-of-its-kind delivery unit has delivered more than 750 babies diagnosed with birth defects before birth.
More than 300 medical experts from around the world gathered in Philadelphia to discuss the most recent advances in prenatal diagnosis and treatment of birth defects.
Nurses lead patient education program for mothers of newborns.